Sarat Chandarlapaty

65PUBLICATIONS
418CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTissue engineeringCancer geneticsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Oct 10, 2026
CDKPredict: a clinicogenomic model for risk-adapted therapeutic intervention in breast cancer.

|Sep 09, 2026
ERBB2 Activating Mutations Promote Enhanced Internalization and Activity of Trastuzumab Deruxtecan in HER2-non-amplified Metastatic Breast Cancer.

|Aug 12, 2026
Rb-driven transcription limits its tumour-suppressive effects in breast cancer.

|Jul 17, 2026
Microfluidic Tissue Array Platform for Personalized Drug Screening Using Tumor Explants or Biopsies.

|Mar 04, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Anton Safonov, Minna Lee, David N Brown

|Dec 20, 2025
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer.

Ziyu Chen, Xinran Tang, Jordan E Eichholz

Pageof 11

Frequent Collaborators

19 joint publications

Pedram Razavi

13 joint publications

Fresia Pareja

10 joint publications

Britta Weigelt

9 joint publications

Antonio Marra